Investigating neutrophil AMPK activity in COVID-19 and pneumonia
Y. Giam (Dundee (Angus), United Kingdom), M. Long (Dundee (Angus), United Kingdom), L. Delgado (Dundee (Angus), United Kingdom), H. Abo-Leyah (Dundee (Angus), United Kingdom), H. Keir (Dundee (Angus), United Kingdom), T. Pembridge (Dundee (Angus), United Kingdom), R. Hull (Sheffield, United Kingdom), A. Gilmour (Dundee (Angus), United Kingdom), C. Hughes (Dundee (Angus), United Kingdom), H. Richardson (Dundee (Angus), United Kingdom), D. Cassidy (Dundee (Angus), United Kingdom), A. Shoemark (Dundee (Angus), United Kingdom), J. Chalmers (Dundee (Angus), United Kingdom)
Source: International Congress 2022 – Pneumonia
Session: Pneumonia
Session type: Oral Presentation
Number: 4404
   
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Giam (Dundee (Angus), United Kingdom), M. Long (Dundee (Angus), United Kingdom), L. Delgado (Dundee (Angus), United Kingdom), H. Abo-Leyah (Dundee (Angus), United Kingdom), H. Keir (Dundee (Angus), United Kingdom), T. Pembridge (Dundee (Angus), United Kingdom), R. Hull (Sheffield, United Kingdom), A. Gilmour (Dundee (Angus), United Kingdom), C. Hughes (Dundee (Angus), United Kingdom), H. Richardson (Dundee (Angus), United Kingdom), D. Cassidy (Dundee (Angus), United Kingdom), A. Shoemark (Dundee (Angus), United Kingdom), J. Chalmers (Dundee (Angus), United Kingdom). Investigating neutrophil AMPK activity in COVID-19 and pneumonia. 4404
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|